Pular para conteúdo

Obstetrícia

Manejo da trombocitopenia

Rescue therapy with romiplostim for refractory primary immune thrombocytopenia during pregnancy. (abre nova janela)

Decroocq J, Marcellin L, Le Ray C, Willems L.

Fonte‎: Obstet Gynecol 2014;124(2 Pt 2 Suppl 1):481-3.

Indexado‎: PubMed 25004319

DOI‎: 10.1097/AOG.0000000000000371

https://www.ncbi.nlm.nih.gov/pubmed/25004319 (abre nova janela)

Use of thrombopoietin receptor agonists for immune thrombocytopenia in pregnancy: results from a multicenter study. (abre nova janela)

Michel M, Ruggeri M, Gonzalez-Lopez TJ, Alkindi SS, Cheze S, Ghanima W, Tvedt THA, Ebbo M, Terriou L, Bussel JB, Godeau B

Fonte‎: Blood 2020;136(26):3056-61.

Indexado‎: PubMed 32814348

DOI‎: 10.1182/blood.2020007594

https://www.ncbi.nlm.nih.gov/pubmed/32814348 (abre nova janela)

A case of refractory immune thrombocytopenia in pregnancy managed with elthrombopag. (abre nova janela)

Purushothaman J, Puthumana KJ, Kumar A, Innah SJ, Gilvaz S.

Fonte‎: Asian J Transfus Sci 2016;10(2):155-8.

Indexado‎: PubMed 27605856

DOI‎: 10.4103/0973-6247.177204

https://www.ncbi.nlm.nih.gov/pubmed/27605856 (abre nova janela)

Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study. (abre nova janela)

Saleh MN, Bussel JB, Cheng G, Meyer O, Bailey CK, Arning M, Brainsky A; EXTEND Study Group.

Fonte‎: Blood 2013;121(3):537-45.

Indexado‎: PubMed 23169778

https://www.ncbi.nlm.nih.gov/pubmed/23169778 (abre nova janela)